BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24035280)

  • 21. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.
    Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS
    Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclooxygenase-2 has no impact on survival in adenocarcinoma of the esophagogastric junction but is associated with favourable clinicopathologic features.
    Knief J; Reddemann K; Petrova E; Herhahn T; Wellner U; Thorns C
    Histol Histopathol; 2017 Jul; 32(7):735-741. PubMed ID: 27854106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal junction and gastroesophageal junction carcinoma : a short update.
    Ekmektzoglou KA; Apostolopoulos P; Samelis G; Alexandrakis G
    Acta Gastroenterol Belg; 2016; 79(4):471-479. PubMed ID: 28209106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer.
    Liu WJ; Zhao YP; Zhang TP; Zhou L; Cui QC; Zhou WX; You L; Chen G; Shu H
    J Gastrointest Surg; 2013 Aug; 17(8):1399-405. PubMed ID: 23715647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
    Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
    J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
    Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
    Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Fhit, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype.
    Hara A; Yashima K; Yasugi A; Koda M; Kawaguchi K; Harada K; Andachi H; Shiota G; Ito H; Murawaki Y
    Oncol Rep; 2007 Sep; 18(3):553-9. PubMed ID: 17671701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.
    Yang LP; Fu LC; Guo H; Xie LX
    Onkologie; 2012; 35(3):88-93. PubMed ID: 22414971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas.
    Gu MJ; Bae YK; Kim A; Hong SM; Yu E; Kim J; Jang KT; Chang HK; Jung ES; Bae HI; Yoon GS; Kim JM; Kim JY; Kim GI; Oh YH; Jang KY; Jun SY; Eom DW; Kwon KW; Kang GH; Park JB; Hong SW; Jung SJ; Lee JS;
    Hepatogastroenterology; 2012 Oct; 59(119):2228-32. PubMed ID: 22456432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
    Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
    Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl-CpG targeted recruitment of p300 reactivates tumor suppressor genes in human cancer cells.
    Fukushige S; Kondo E; Horii A
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1021-6. PubMed ID: 19146826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of N-cadherin expression in gastric cancer.
    Kamikihara T; Ishigami S; Arigami T; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Ueno S; Natsugoe S
    Pathol Int; 2012 Mar; 62(3):161-6. PubMed ID: 22360503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
    Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine.
    Lin F; Shi J; Zhu S; Chen Z; Li A; Chen T; Wang HL; Liu H
    Arch Pathol Lab Med; 2014 Aug; 138(8):1015-26. PubMed ID: 24437456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.
    Madani SH; Rahmati A; Sadeghi E; Khazaei S; Sadeghi M; Payandeh M; Amirifard N
    Asian Pac J Cancer Prev; 2015; 16(17):7755-8. PubMed ID: 26625793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
    Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Dong H; Chen Y; Liu Q; Wu X; Zhou D; Tan D; Zhang H
    PLoS One; 2013; 8(11):e80665. PubMed ID: 24236193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.